Showing 893 results
-
Media Release /Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1 Remibrutinib, a highly selective oral BTK inhibitor, was well-…
-
Media Release /In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1 Results favored Vanrafia across multiple…
-
Media Release /NFL Icons Coach Bruce Arians, Rob Gronkowski, George Kittle and more partner with Novartis to prioritize early prostate cancer detection One in eight men will face prostate cancer1, yet…
-
Event / Aug 28, 2026
-
Event / Jul 18, 2026
-
Event / Sep 12, 2026
-
Event / Aug 16, 2026
-
Statement /
